pyridostigmine bromide has been researched along with interleukin-8 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baynes, RE; Monteiro-Riviere, NA; Riviere, JE | 1 |
| Clarke, G; Cooney, J; Cryan, J; Dinan, TG; Keeling, PW; Quigley, EM; Scott, LV; Shanahan, F | 1 |
2 other study(ies) available for pyridostigmine bromide and interleukin-8
| Article | Year |
|---|---|
Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin.
Topics: Administration, Cutaneous; Animals; Cells, Cultured; Cholinesterase Inhibitors; Cytokines; DEET; Dinoprostone; Drug Interactions; Female; Humans; In Vitro Techniques; Insect Repellents; Insecticides; Interleukin-8; Keratinocytes; Permethrin; Persian Gulf Syndrome; Pyridostigmine Bromide; Skin; Skin Absorption; Swine; Tumor Necrosis Factor-alpha | 2003 |
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Biomarkers; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-10; Interleukin-6; Interleukin-8; Irritable Bowel Syndrome; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Procyclidine; Prognosis; Pyridostigmine Bromide; Radioimmunoassay; Receptors, Muscarinic | 2008 |